Skip to main content
Top
Published in: Clinical and Experimental Nephrology 3/2017

01-06-2017 | Original article

Quantification of autonomic nervous activity by heart rate variability and approximate entropy in high ultrafiltration rate during hemodialysis

Authors: Yoshihiro Tsuji, Naoki Suzuki, Yasumasa Hitomi, Toshiko Yoshida, Yuko Mizuno-Matsumoto

Published in: Clinical and Experimental Nephrology | Issue 3/2017

Login to get access

Abstract

Background

Few studies have focused on the imbalance of the autonomic nervous system in ultrafiltration rate (UFR) subjects without blood pressure variation during maintenance hemodialysis (HD), although the role of autonomic nervous system activation during HD has been proposed to be an important factor for the maintenance of blood pressure.

Methods

Variations over time in autonomic nervous activity due to differences in UFR were evaluated by measuring heart rate variability (HRV) and approximate entropy (ApEn) in 35 HD patients without blood pressure variations during HD session. The subjects were divided into 3 groups, those with UFR <10 ml/h/kg; ≥10 ml/h/kg but ≤15 ml/h/kg; and >15 ml/h/kg, and Holter ECG was recorded continuously during HD session using frequency analysis of RR intervals. High frequency (HF) and low frequency (LF) spectral components are found to be representative of the parasympathetic nervous system and sympathovagal balance, respectively, with the ratio of LF to HF of HRV providing a measure of sympathetic nervous system.

Results

In subjects with UFR >15 ml/h/kg, HF components were significantly lower, and LF/HF and ApEn values were significantly higher, in the latter half of an HD session than before starting HD.

Conclusion

Removing water from these subjects would promote sustained sympathetic nervous overactivity. These findings indicate that the UFR during HD needs to be set at ≤15 ml/h/kg.
Literature
1.
go back to reference Nakai S, Hanafusa N, Masakane I, Taniguchi M, Hamano T, Shoji T, Hasegawa T, Itami N, Yamagata K, Shinoda T, Kazama JJ, Watanabe Y, Shigematsu T, Marubayashi S, Morita O, Wada A, Hashimoto S, Suzuki K, Nakamoto H, Kimata N, Wakai K, Fujii N, Ogata S, Tsuchida K, Nishi H, Iseki K. An overview of regular dialysis treatment in Japan (as of Decenber 31, 2012). Ther Apher Dial. 2014;18(6):535–602.CrossRefPubMed Nakai S, Hanafusa N, Masakane I, Taniguchi M, Hamano T, Shoji T, Hasegawa T, Itami N, Yamagata K, Shinoda T, Kazama JJ, Watanabe Y, Shigematsu T, Marubayashi S, Morita O, Wada A, Hashimoto S, Suzuki K, Nakamoto H, Kimata N, Wakai K, Fujii N, Ogata S, Tsuchida K, Nishi H, Iseki K. An overview of regular dialysis treatment in Japan (as of Decenber 31, 2012). Ther Apher Dial. 2014;18(6):535–602.CrossRefPubMed
2.
go back to reference Flythe JE, Kimmel SE, Brunelli SM. Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int. 2011;79(2):250–7.CrossRefPubMed Flythe JE, Kimmel SE, Brunelli SM. Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int. 2011;79(2):250–7.CrossRefPubMed
3.
go back to reference Leypoldt JK, Cheung AK, Delmez JA, Gassman JJ, Levin NW, Lewis JA, Lewis JL, Rocco MV. Relationship between volume status and blood pressure during chronic hemodialysis. Kidney Int. 2002;61(1):266–75.CrossRefPubMed Leypoldt JK, Cheung AK, Delmez JA, Gassman JJ, Levin NW, Lewis JA, Lewis JL, Rocco MV. Relationship between volume status and blood pressure during chronic hemodialysis. Kidney Int. 2002;61(1):266–75.CrossRefPubMed
4.
go back to reference Rubinger D, Backenroth R, Sapoznikov D. Sympathetic activation and baroreflex function during intradialytic hypertensive episodes. PLoS One. 2012;7(5):e36943.CrossRefPubMedPubMedCentral Rubinger D, Backenroth R, Sapoznikov D. Sympathetic activation and baroreflex function during intradialytic hypertensive episodes. PLoS One. 2012;7(5):e36943.CrossRefPubMedPubMedCentral
5.
go back to reference Richman JS, Moorman JR. Physiological time-series analysis using approximate entropy and sample entropy. Am J Physiol Heart Circ Physiol. 2000;278(6):H2039–49.PubMed Richman JS, Moorman JR. Physiological time-series analysis using approximate entropy and sample entropy. Am J Physiol Heart Circ Physiol. 2000;278(6):H2039–49.PubMed
6.
go back to reference Movilli E, Gaggia P, Zubani R, Camerini C, Vizzardi V, Parrinello G, Savoldi S, Fischer MS, Londrino F, Cancarini G. Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. Nephrol Dial Transpl. 2007;22(12):3547–52 (Epub 2007 Sep 21).CrossRef Movilli E, Gaggia P, Zubani R, Camerini C, Vizzardi V, Parrinello G, Savoldi S, Fischer MS, Londrino F, Cancarini G. Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. Nephrol Dial Transpl. 2007;22(12):3547–52 (Epub 2007 Sep 21).CrossRef
7.
go back to reference Oikawa K, Ishihara R, Maeda T, Yamaguchi K, Koike A, Kawaguchi H, Tabata Y, Murotani N, Itoh H. Prognostic value of heart rate variability in patients with renal failure on hemodialysis. Int J Cardiol. 2009;131(3):370–7.CrossRefPubMed Oikawa K, Ishihara R, Maeda T, Yamaguchi K, Koike A, Kawaguchi H, Tabata Y, Murotani N, Itoh H. Prognostic value of heart rate variability in patients with renal failure on hemodialysis. Int J Cardiol. 2009;131(3):370–7.CrossRefPubMed
8.
go back to reference Tarvainen MP, Niskanen JP, Lipponen JA, Ranta-Aho PO, Karjalainen PA. Kubios HRV—heart rate variability analysis software. Comput Methods Programs Biomed. 2014;113(1):210–20.CrossRefPubMed Tarvainen MP, Niskanen JP, Lipponen JA, Ranta-Aho PO, Karjalainen PA. Kubios HRV—heart rate variability analysis software. Comput Methods Programs Biomed. 2014;113(1):210–20.CrossRefPubMed
9.
go back to reference Task Force of the European Society of Cardiology, the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task force of the European Society of cardiology and the North American Society of pacing and electrophysiology. Circulation. 1996;93(5):1043–65.CrossRef Task Force of the European Society of Cardiology, the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task force of the European Society of cardiology and the North American Society of pacing and electrophysiology. Circulation. 1996;93(5):1043–65.CrossRef
10.
go back to reference Zhong Y, Wang H, Ju KH, Jan KM, Chon KH. Nonlinear analysis of the separate contributions of autonomic nervous systems to heart rate variability using principal dynamic modes. IEEE Trans Biomed Eng. 2004;51(2):255–62.CrossRefPubMed Zhong Y, Wang H, Ju KH, Jan KM, Chon KH. Nonlinear analysis of the separate contributions of autonomic nervous systems to heart rate variability using principal dynamic modes. IEEE Trans Biomed Eng. 2004;51(2):255–62.CrossRefPubMed
11.
12.
go back to reference Panza JA, Diodati JG, Callahan TS, Epstein SE, Quyyumi AA. Role of increases in heart rate in determining the occurrence and frequency of myocardial ischemia during daily life in patients with stable coronary artery disease. J Am Coll Cardiol. 1992;20(5):1092–8.CrossRefPubMed Panza JA, Diodati JG, Callahan TS, Epstein SE, Quyyumi AA. Role of increases in heart rate in determining the occurrence and frequency of myocardial ischemia during daily life in patients with stable coronary artery disease. J Am Coll Cardiol. 1992;20(5):1092–8.CrossRefPubMed
13.
go back to reference Lanitz EC, Gonska BD, Schrader J. Blood pressure variability and transient myocardial ischemia in patients with essential hypertension. Z Kardiol. 1992;81(Suppl 2):37–9 (German).PubMed Lanitz EC, Gonska BD, Schrader J. Blood pressure variability and transient myocardial ischemia in patients with essential hypertension. Z Kardiol. 1992;81(Suppl 2):37–9 (German).PubMed
14.
go back to reference Andrews TC, Fenton T, Toyosaki N, Glasser SP, Young PM, MacCallum G, Gibson RS, Shook TL, Stone PH. Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS). Circulation. 1993;88(1):92–100.CrossRefPubMed Andrews TC, Fenton T, Toyosaki N, Glasser SP, Young PM, MacCallum G, Gibson RS, Shook TL, Stone PH. Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS). Circulation. 1993;88(1):92–100.CrossRefPubMed
15.
go back to reference Goseki Y, Matsubara T, Takahashi N, Takeuchi T, Ibukiyama C. Heart rate variability before the occurrence of silent myocardial ischemia during ambulatory monitoring. Am J Cardiol. 1994;73(12):845–9.CrossRefPubMed Goseki Y, Matsubara T, Takahashi N, Takeuchi T, Ibukiyama C. Heart rate variability before the occurrence of silent myocardial ischemia during ambulatory monitoring. Am J Cardiol. 1994;73(12):845–9.CrossRefPubMed
Metadata
Title
Quantification of autonomic nervous activity by heart rate variability and approximate entropy in high ultrafiltration rate during hemodialysis
Authors
Yoshihiro Tsuji
Naoki Suzuki
Yasumasa Hitomi
Toshiko Yoshida
Yuko Mizuno-Matsumoto
Publication date
01-06-2017
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 3/2017
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-016-1305-5

Other articles of this Issue 3/2017

Clinical and Experimental Nephrology 3/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.